Therapeutic granulocyte transfusions for the treatment of febrile neutropenia in patients with hematologic diseases: a 10-year experience at a single institute

References

• Cherif H, Kronvall G, Bjorkholm M, Kalin M. Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis. Hematol J. 2003;4:420–6.
   PubMedGoogle Scholar
• Klastersky J. Empirical treatment of sepsis in neutropenic patients. Hosp Med. 2001;62:101–3.
   PubMedGoogle Scholar
• Worth LJ, Slavin MA. Bloodstream infections in haematology: risks and new challenges for prevention. Blood Rev. 2009;23:113–22.
   Google Scholar
• Segal AW. How neutrophils kill microbes. Annu Rev Immunol. 2005;23:197–223.
   PubMed Web of Science ®Google Scholar
• Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966;64:328–40.
   PubMed Web of Science ®Google Scholar
• Strumia M. The effect of leukocytic cream injections in the treatment of the neutropenias. Am J Med Sci. 1934;187:527.
   Google Scholar
• Alavi JB, Root RK, Djerassi I, Evans AE, Gluckman SJ, MacGregor RR, . A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med. 1977;296:706–11.
   PubMed Web of Science ®Google Scholar
• Bow EJ, Schroeder ML, Louie TJ. Pulmonary complications in patients receiving granulocyte transfusions and amphotericin B. Can Med Assoc J. 1984;130:593–7.
   PubMed Web of Science ®Google Scholar
• Herzig RH, Herzig GP, Graw RG Jr, Bull MI, Ray KK. Successful granulocyte transfusion therapy for gram-negative septicemia. A prospectively randomized controlled study. N Engl J Med. 1977;296:701–5.
   PubMed Web of Science ®Google Scholar
• Higby DJ, Yates JW, Henderson ES, Holland JF. Filtration leukapheresis for granulocyte transfusion therapy. Clinical and laboratory studies. N Engl J Med. 1975;292:761–6.
   PubMed Web of Science ®Google Scholar
• Price TH. Granulocyte transfusion: current status. Semin Hematol. 2007;44:15–23.
   Google Scholar
• Scali G, von Felten A, Fehr J, Sauter C, Gmur J. [Granulocyte substitution in febrile leukemia patients with bone marrow aplasia. I. Results of a prospective study]. Schweiz Med Wochenschr. 1978;108:1583–5.
   Google Scholar
• Stanworth SJ, Massey E, Hyde C, Brunskill S, Lucas G, Navarrete C, . Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction. Cochrane Database Syst Rev. (CD005339) 2005;3:1–29.
   Google Scholar
• Vogler WR, Winton EF. A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia. Am J Med. 1977;63:548–55.
   PubMed Web of Science ®Google Scholar
• Winston DJ, Ho WG, Gale RP. Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninety-five infectious granulocytopenic episodes. Ann Intern Med. 1982;97:509–15.
   PubMed Web of Science ®Google Scholar
• Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, . 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002;34:730–51.
   PubMed Web of Science ®Google Scholar
• Hughes WT, Armstrong D, Bodey GP, Brown AE, Edwards JE, Feld R, . 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin Infect Dis. 1997;25:551–73.
   PubMed Web of Science ®Google Scholar
• Grigull L, Pulver N, Goudeva L, Sykora KW, Linderkamp C, Beilken A, . G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis. Support Care Cancer. 2006;14:910–6.
   PubMed Web of Science ®Google Scholar
• Peters C, Minkov M, Matthes-Martin S, Potschger U, Witt V, Mann G, . Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients. Br J Haematol. 1999;106:689–96.
   PubMed Web of Science ®Google Scholar
• Sachs UJ, Reiter A, Walter T, Bein G, Woessmann W. Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections. Transfusion. 2006;46:1909–14.
   PubMed Web of Science ®Google Scholar
• Atallah E, Schiffer CA. Granulocyte transfusion. Curr Opin Hematol. 2006;13:45–9.
   PubMed Web of Science ®Google Scholar
• Bensinger WI, Price TH, Dale DC, Appelbaum FR, Clift R, Lilleby K, . The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood. 1993;81:1883–8.
   PubMed Web of Science ®Google Scholar
• Quillen K, Yau YY, Leitman SF. The determinants of granulocyte yield in 1198 granulocyte concentrates collected from unrelated volunteer donors mobilized with dexamethasone and granulocyte-colony-stimulating factor: a 13-year experience. Transfusion. 2009;49:421–6.
   Google Scholar
• Anderlini P. Effects and safety of granulocyte colony-stimulating factor in healthy volunteers. Curr Opin Hematol. 2009;16:35–40.
   PubMed Web of Science ®Google Scholar
• Anderlini P, Przepiorka D, Seong D, Miller P, Sundberg J, Lichtiger B, . Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures. Transfusion. 1996;36:590–5.
   PubMed Web of Science ®Google Scholar
• Stroncek DF, Clay ME, Petzoldt ML, Smith J, Jaszcz W, Oldham FB, . Treatment of normal individuals with granulocyte–colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion. 1996;36:601–10.
   PubMed Web of Science ®Google Scholar
• Quillen K, Byrne P, Yau YY, Leitman SF. Ten-year follow-up of unrelated volunteer granulocyte donors who have received multiple cycles of granulocyte–colony-stimulating factor and dexamethasone. Transfusion. 2009;49:513–8.
   Google Scholar
• Strauss RG. Granulocyte (neutrophil) transfusion. Strauss RG. Apheresis: Principles and Practice. 2nd. Bethesda: AABB Press; 2003. 237–52.
   Google Scholar
• Engelfriet CP, Reesink HW, Klein HG, Murphy MF, Pamphilon D, Devereux S, . International forum: granulocyte transfusions. Vox Sang. 2000;79:59–66.
   PubMedGoogle Scholar
• Vamvakas EC, Pineda AA. Meta-analysis of clinical studies of the efficacy of granulocyte transfusions in the treatment of bacterial sepsis. J Clin Apher. 1996;11:1–9.
   PubMedGoogle Scholar
• Seidel MG, Minkov M, Witt V, Matthes-Martin S, Potschger U, Worel N, . Granulocyte transfusions in children and young adults: does the dose matter? J Pediatr Hematol Oncol. 2009;31:166–72.
   PubMed Web of Science ®Google Scholar
• Quillen K, Wong E, Scheinberg P, Young NS, Walsh TJ, Wu CO, . Granulocyte transfusions in severe aplastic anemia: an eleven-year experience. Haematologica. 2009;94:1661–8.
   PubMed Web of Science ®Google Scholar
• Hubel K, Carter RA, Liles WC, Dale DC, Price TH, Bowden RA, . Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors. Transfusion. 2002;42:1414–21.
   PubMed Web of Science ®Google Scholar
• Illerhaus G, Wirth K, Dwenger A, Waller CF, Garbe A, Brass V, . Treatment and prophylaxis of severe infections in neutropenic patients by granulocyte transfusions. Ann Hematol. 2002;81:273–81.
   PubMed Web of Science ®Google Scholar
• Mousset S, Hermann S, Klein SA, Bialleck H, Duchscherer M, Bomke B, . Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia. Ann Hematol. 2005;84:734–41.
   PubMed Web of Science ®Google Scholar
• Seidel MG, Peters C, Wacker A, Northoff H, Moog R, Boehme A, . Randomized phase III study of granulocyte transfusions in neutropenic patients. Bone Marrow Transplant. 2008;42:679–84.
   PubMed Web of Science ®Google Scholar
• Lee JJ, Chung IJ, Park MR, Kook H, Hwang TJ, Ryang DW, . Clinical efficacy of granulocyte transfusion therapy in patients with neutropenia-related infections. Leukemia. 2001;15:203–7.
   PubMed Web of Science ®Google Scholar
• Lee JJ, Song HC, Chung IJ, Bom HS, Cho D, Kim HJ. Clinical efficacy and prediction of response to granulocyte transfusion therapy for patients with neutropenia-related infections. Haematologica. 2004;89:632–3.
   PubMed Web of Science ®Google Scholar